A comparative assessment of the clinical impact of clonal Pseudomonas aeruginosa strains in people with cystic fibrosis (CF).

A/Prof Scott Bell (Principle Investigator)0 sites1,500 target enrollmentJune 28, 2007

Overview

Phase: 未知
Intervention: Not specified
Conditions: Clonal P. aeruginosa infection in patients with cystic fibrosis.
Sponsor: A/Prof Scott Bell (Principle Investigator)
Enrollment: 1500
Status: Recruiting
Last Updated: 6 years ago

No summary available.

Registry

who.int

Start Date

June 28, 2007

End Date

TBD

Last Updated

6 years ago

Study Type

Observational

Sex

All

Sponsor

A/Prof Scott Bell (Principle Investigator)

•Children, adolescents and adults (both males and females) with CF who can produce a spontaneously expectorated sputum sample with evidence of P. aeruginosa (this will apply to both the Prevalence and Observational Studies). 2\) Following the Cross sectional Study, only those patients without evidence of clonal strains will continue to have samples and clinical data collected for the Observational Study.

•1\) Patient's that are unable to produce a spontaneously expectorated sputum sample or those who have no evidence of P. aeruginosa. 2\) Patient's with evidence of a clonal strain at the completion of the Prevalence Study, will not be included in the Observational Study. 3\) Any patient that is unable or unwilling to provide written informed consent.